nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—CYP2C9—urine—polycystic ovary syndrome	0.0491	0.109	CbGeAlD
Diclofenamide—CA5A—endocrine gland—polycystic ovary syndrome	0.0434	0.0964	CbGeAlD
Diclofenamide—CA14—adrenal gland—polycystic ovary syndrome	0.0277	0.0616	CbGeAlD
Diclofenamide—CA9—endocrine gland—polycystic ovary syndrome	0.0253	0.0563	CbGeAlD
Diclofenamide—CA5B—adipose tissue—polycystic ovary syndrome	0.0216	0.048	CbGeAlD
Diclofenamide—CA5B—adrenal gland—polycystic ovary syndrome	0.0194	0.0431	CbGeAlD
Diclofenamide—CA1—adipose tissue—polycystic ovary syndrome	0.0191	0.0424	CbGeAlD
Diclofenamide—CA2—embryo—polycystic ovary syndrome	0.0188	0.0417	CbGeAlD
Diclofenamide—CA12—endocrine gland—polycystic ovary syndrome	0.0187	0.0417	CbGeAlD
Diclofenamide—CA5B—vagina—polycystic ovary syndrome	0.018	0.0399	CbGeAlD
Diclofenamide—CA5B—endocrine gland—polycystic ovary syndrome	0.0168	0.0374	CbGeAlD
Diclofenamide—CA2—adrenal cortex—polycystic ovary syndrome	0.0154	0.0342	CbGeAlD
Diclofenamide—CA4—pituitary gland—polycystic ovary syndrome	0.015	0.0333	CbGeAlD
Diclofenamide—CA4—adipose tissue—polycystic ovary syndrome	0.0149	0.0332	CbGeAlD
Diclofenamide—CA1—endocrine gland—polycystic ovary syndrome	0.0149	0.033	CbGeAlD
Diclofenamide—CA4—adrenal gland—polycystic ovary syndrome	0.0134	0.0297	CbGeAlD
Diclofenamide—CA4—female gonad—polycystic ovary syndrome	0.0125	0.0277	CbGeAlD
Diclofenamide—CA2—pituitary gland—polycystic ovary syndrome	0.0124	0.0276	CbGeAlD
Diclofenamide—CA2—adipose tissue—polycystic ovary syndrome	0.0124	0.0275	CbGeAlD
Diclofenamide—CA4—endocrine gland—polycystic ovary syndrome	0.0116	0.0258	CbGeAlD
Diclofenamide—CA2—adrenal gland—polycystic ovary syndrome	0.0111	0.0247	CbGeAlD
Diclofenamide—CA2—female gonad—polycystic ovary syndrome	0.0103	0.023	CbGeAlD
Diclofenamide—CA2—vagina—polycystic ovary syndrome	0.0103	0.0229	CbGeAlD
Diclofenamide—CA2—endocrine gland—polycystic ovary syndrome	0.00963	0.0214	CbGeAlD
Diclofenamide—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00814	0.0181	CbGeAlD
Diclofenamide—CA9—Metabolism—PNPLA2—polycystic ovary syndrome	0.00114	0.00208	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—HMMR—polycystic ovary syndrome	0.00114	0.00207	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CYP11A1—polycystic ovary syndrome	0.00114	0.00207	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—RRM2—polycystic ovary syndrome	0.00113	0.00206	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—RRM2—polycystic ovary syndrome	0.00113	0.00206	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—NAMPT—polycystic ovary syndrome	0.00112	0.00204	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—NAMPT—polycystic ovary syndrome	0.00112	0.00204	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00112	0.00203	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CYP11A1—polycystic ovary syndrome	0.00111	0.00202	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CYP11A1—polycystic ovary syndrome	0.00111	0.00202	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—HMMR—polycystic ovary syndrome	0.00109	0.00199	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—YAP1—polycystic ovary syndrome	0.00109	0.00199	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—YAP1—polycystic ovary syndrome	0.00109	0.00199	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—HSD3B1—polycystic ovary syndrome	0.00109	0.00198	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—SULT2A1—polycystic ovary syndrome	0.00108	0.00197	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—SRD5A1—polycystic ovary syndrome	0.00108	0.00197	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—AKR1C3—polycystic ovary syndrome	0.00108	0.00196	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CYP17A1—polycystic ovary syndrome	0.00106	0.00193	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—RRM2—polycystic ovary syndrome	0.00105	0.00191	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—NAMPT—polycystic ovary syndrome	0.00105	0.00191	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—NAMPT—polycystic ovary syndrome	0.00105	0.00191	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—AKR1C3—polycystic ovary syndrome	0.00105	0.00191	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—AKR1C3—polycystic ovary syndrome	0.00105	0.00191	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—HMMR—polycystic ovary syndrome	0.00105	0.00191	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—HSD3B1—polycystic ovary syndrome	0.00104	0.0019	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00104	0.0019	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CYP11A1—polycystic ovary syndrome	0.00104	0.00189	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CYP11A1—polycystic ovary syndrome	0.00104	0.00189	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—STAR—polycystic ovary syndrome	0.00103	0.00188	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CYP17A1—polycystic ovary syndrome	0.00103	0.00188	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CYP17A1—polycystic ovary syndrome	0.00103	0.00188	CbGpPWpGaD
Diclofenamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00103	0.00188	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00103	0.00187	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—YAP1—polycystic ovary syndrome	0.00101	0.00184	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—HSD3B1—polycystic ovary syndrome	0.001	0.00182	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—LHB—polycystic ovary syndrome	0.000993	0.0018	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00099	0.0018	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—AKR1C3—polycystic ovary syndrome	0.000979	0.00178	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—AKR1C3—polycystic ovary syndrome	0.000979	0.00178	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—NAMPT—polycystic ovary syndrome	0.000973	0.00177	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—HSD3B2—polycystic ovary syndrome	0.00097	0.00176	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CYP17A1—polycystic ovary syndrome	0.000964	0.00175	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CYP17A1—polycystic ovary syndrome	0.000964	0.00175	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CYP11A1—polycystic ovary syndrome	0.000961	0.00175	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—LHB—polycystic ovary syndrome	0.000952	0.00173	CbGpPWpGaD
Diclofenamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000949	0.00172	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—AKR1C1—polycystic ovary syndrome	0.00094	0.00171	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—HSD3B2—polycystic ovary syndrome	0.00093	0.00169	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000924	0.00168	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—HMMR—polycystic ovary syndrome	0.000922	0.00168	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—TH—polycystic ovary syndrome	0.000917	0.00167	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—LHB—polycystic ovary syndrome	0.000912	0.00166	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000911	0.00166	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—AKR1C3—polycystic ovary syndrome	0.000907	0.00165	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000901	0.00164	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—TH—polycystic ovary syndrome	0.000893	0.00162	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—TH—polycystic ovary syndrome	0.000893	0.00162	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CYP17A1—polycystic ovary syndrome	0.000893	0.00162	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—SLC2A4—polycystic ovary syndrome	0.000892	0.00162	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000892	0.00162	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—HSD3B1—polycystic ovary syndrome	0.00088	0.0016	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000869	0.00158	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—SLC2A4—polycystic ovary syndrome	0.000869	0.00158	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000865	0.00157	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000864	0.00157	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000861	0.00156	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000859	0.00156	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000847	0.00154	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CYP19A1—polycystic ovary syndrome	0.000838	0.00152	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—RRM2—polycystic ovary syndrome	0.000838	0.00152	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—TH—polycystic ovary syndrome	0.000834	0.00152	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—TH—polycystic ovary syndrome	0.000834	0.00152	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000829	0.00151	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CYP19A1—polycystic ovary syndrome	0.000817	0.00149	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000817	0.00149	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000811	0.00148	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—SLC2A4—polycystic ovary syndrome	0.000811	0.00148	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—YAP1—polycystic ovary syndrome	0.000807	0.00147	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—RRM2—polycystic ovary syndrome	0.000803	0.00146	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—LHB—polycystic ovary syndrome	0.000802	0.00146	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000795	0.00145	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000784	0.00143	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000782	0.00142	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000782	0.00142	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—NAMPT—polycystic ovary syndrome	0.000776	0.00141	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—YAP1—polycystic ovary syndrome	0.000774	0.00141	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—TH—polycystic ovary syndrome	0.000773	0.0014	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—RRM2—polycystic ovary syndrome	0.00077	0.0014	CbGpPWpGaD
Diclofenamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000769	0.0014	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000766	0.00139	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CYP19A1—polycystic ovary syndrome	0.000763	0.00139	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CYP19A1—polycystic ovary syndrome	0.000763	0.00139	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000759	0.00138	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—SLC2A4—polycystic ovary syndrome	0.000752	0.00137	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—GNAS—polycystic ovary syndrome	0.000748	0.00136	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—NAMPT—polycystic ovary syndrome	0.000744	0.00135	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—YAP1—polycystic ovary syndrome	0.000742	0.00135	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000734	0.00134	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GNAS—polycystic ovary syndrome	0.000729	0.00133	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GNAS—polycystic ovary syndrome	0.000729	0.00133	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000723	0.00132	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—VEGFA—polycystic ovary syndrome	0.000714	0.0013	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—NCOR1—polycystic ovary syndrome	0.000713	0.0013	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—NAMPT—polycystic ovary syndrome	0.000713	0.0013	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000712	0.00129	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CYP19A1—polycystic ovary syndrome	0.000707	0.00128	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000704	0.00128	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000699	0.00127	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—NCOR1—polycystic ovary syndrome	0.000695	0.00126	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—NCOR1—polycystic ovary syndrome	0.000695	0.00126	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000694	0.00126	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000683	0.00124	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GNAS—polycystic ovary syndrome	0.000681	0.00124	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GNAS—polycystic ovary syndrome	0.000681	0.00124	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00068	0.00124	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—RRM2—polycystic ovary syndrome	0.000677	0.00123	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CYP1A1—polycystic ovary syndrome	0.000676	0.00123	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00067	0.00122	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000665	0.00121	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CYP1A1—polycystic ovary syndrome	0.000659	0.0012	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CYP1A1—polycystic ovary syndrome	0.000659	0.0012	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000656	0.00119	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000655	0.00119	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—YAP1—polycystic ovary syndrome	0.000652	0.00119	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—NCOR1—polycystic ovary syndrome	0.000649	0.00118	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—NCOR1—polycystic ovary syndrome	0.000649	0.00118	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GNAS—polycystic ovary syndrome	0.000631	0.00115	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—MTHFR—polycystic ovary syndrome	0.00063	0.00115	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NAMPT—polycystic ovary syndrome	0.000627	0.00114	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000622	0.00113	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000619	0.00113	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—TH—polycystic ovary syndrome	0.000616	0.00112	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CYP1A1—polycystic ovary syndrome	0.000615	0.00112	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CYP1A1—polycystic ovary syndrome	0.000615	0.00112	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—MTHFR—polycystic ovary syndrome	0.000614	0.00112	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—MTHFR—polycystic ovary syndrome	0.000614	0.00112	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—NCOR1—polycystic ovary syndrome	0.000601	0.00109	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000599	0.00109	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000593	0.00108	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—TH—polycystic ovary syndrome	0.000591	0.00107	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000585	0.00106	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000575	0.00105	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000575	0.00104	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—MTHFR—polycystic ovary syndrome	0.000573	0.00104	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—MTHFR—polycystic ovary syndrome	0.000573	0.00104	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CYP1A1—polycystic ovary syndrome	0.00057	0.00104	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—TH—polycystic ovary syndrome	0.000566	0.00103	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000564	0.00102	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000551	0.001	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000548	0.000996	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00054	0.000982	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CYP19A1—polycystic ovary syndrome	0.00054	0.000982	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—MTHFR—polycystic ovary syndrome	0.000531	0.000966	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000518	0.000942	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PPARG—polycystic ovary syndrome	0.000511	0.000929	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000504	0.000917	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—POMC—polycystic ovary syndrome	0.000504	0.000916	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GNAS—polycystic ovary syndrome	0.000503	0.000915	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—INS—polycystic ovary syndrome	0.000501	0.000911	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PPARG—polycystic ovary syndrome	0.000498	0.000905	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PPARG—polycystic ovary syndrome	0.000498	0.000905	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—TH—polycystic ovary syndrome	0.000498	0.000905	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—IL6—polycystic ovary syndrome	0.000494	0.000897	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—POMC—polycystic ovary syndrome	0.000491	0.000893	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—POMC—polycystic ovary syndrome	0.000491	0.000893	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—INS—polycystic ovary syndrome	0.000488	0.000888	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—INS—polycystic ovary syndrome	0.000488	0.000888	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000484	0.000881	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GNAS—polycystic ovary syndrome	0.000482	0.000877	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000482	0.000876	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—NCOR1—polycystic ovary syndrome	0.000479	0.000871	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PPARG—polycystic ovary syndrome	0.000465	0.000845	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PPARG—polycystic ovary syndrome	0.000465	0.000845	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GNAS—polycystic ovary syndrome	0.000462	0.000841	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00046	0.000836	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—NCOR1—polycystic ovary syndrome	0.000459	0.000835	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—POMC—polycystic ovary syndrome	0.000458	0.000833	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—POMC—polycystic ovary syndrome	0.000458	0.000833	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—INS—polycystic ovary syndrome	0.000456	0.000829	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—INS—polycystic ovary syndrome	0.000456	0.000829	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000455	0.000828	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CYP1A1—polycystic ovary syndrome	0.000454	0.000826	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000449	0.000817	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000441	0.000801	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000441	0.000801	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—NCOR1—polycystic ovary syndrome	0.00044	0.000801	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000436	0.000792	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000435	0.000791	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PPARG—polycystic ovary syndrome	0.000431	0.000783	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—POMC—polycystic ovary syndrome	0.000425	0.000772	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—MTHFR—polycystic ovary syndrome	0.000424	0.00077	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—INS—polycystic ovary syndrome	0.000422	0.000768	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000418	0.000759	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.00041	0.000745	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000409	0.000743	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GNAS—polycystic ovary syndrome	0.000406	0.000739	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—MTHFR—polycystic ovary syndrome	0.000406	0.000738	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000401	0.000728	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—MTHFR—polycystic ovary syndrome	0.000389	0.000708	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NCOR1—polycystic ovary syndrome	0.000387	0.000704	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000374	0.00068	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYP1A1—polycystic ovary syndrome	0.000367	0.000667	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000355	0.000645	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000348	0.000633	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000348	0.000633	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PPARG—polycystic ovary syndrome	0.000343	0.000624	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—MTHFR—polycystic ovary syndrome	0.000342	0.000622	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—POMC—polycystic ovary syndrome	0.000339	0.000616	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—INS—polycystic ovary syndrome	0.000337	0.000612	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000335	0.000609	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00033	0.0006	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PPARG—polycystic ovary syndrome	0.000329	0.000599	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—POMC—polycystic ovary syndrome	0.000325	0.00059	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—INS—polycystic ovary syndrome	0.000323	0.000587	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PPARG—polycystic ovary syndrome	0.000316	0.000574	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—POMC—polycystic ovary syndrome	0.000311	0.000566	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—INS—polycystic ovary syndrome	0.00031	0.000563	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000292	0.000531	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PPARG—polycystic ovary syndrome	0.000278	0.000505	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000277	0.000503	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—POMC—polycystic ovary syndrome	0.000274	0.000498	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—INS—polycystic ovary syndrome	0.000272	0.000495	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000264	0.00048	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000261	0.000475	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000235	0.000428	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000225	0.000408	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000222	0.000404	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00021	0.000383	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000205	0.000372	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.0002	0.000364	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000194	0.000352	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000178	0.000324	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000173	0.000314	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	0.000167	0.000303	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	0.00016	0.000291	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000159	0.000289	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000158	0.000287	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000157	0.000285	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000149	0.000271	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000147	0.000267	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—TH—polycystic ovary syndrome	0.000127	0.000231	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000124	0.000225	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000116	0.000211	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	0.000104	0.000189	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	9.88e-05	0.00018	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	9.37e-05	0.00017	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	8.74e-05	0.000159	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	7.08e-05	0.000129	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	6.99e-05	0.000127	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—INS—polycystic ovary syndrome	6.95e-05	0.000126	CbGpPWpGaD
